Citation: | YANG Jie, WANG Benxiao, WANG Junjun. Correlations between serum microRNA-210, interleukin-17 levels and degree of carotid artery stenosisin patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 31-34. DOI: 10.7619/jcmp.20211119 |
[1] |
吴蓓蓓, 陈旭. 重组组织型纤溶酶原激活剂静脉溶栓治疗早期急性脑梗死的疗效及安全性分析[J]. 实用临床医药杂志, 2019, 23(5): 42-45. doi: 10.7619/jcmp.201905011
|
[2] |
NI T, FU Y, ZHOU W, et al. Carotid plaques and neurological impairment in patients with acute cerebral infarction[J]. PLoS One, 2020, 15(1): e0226961. doi: 10.1371/journal.pone.0226961
|
[3] |
JIANG Y L, LIU W W, WANG Y, et al. Expression of Concern: MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2020, 24(17): 8621.
|
[4] |
江钰, 万智, 吕光耀, 等. 急性脑梗死患者血清miR-151a-3p和miR-210的表达及其与炎性因子的关系[J]. 疑难病杂志, 2018, 17(10): 1112-1116. doi: 10.3969/j.issn.1671-6450.2018.10.008
|
[5] |
马伟涛, 夏大胜, 夏伟, 等. 冠状动脉支架内再狭窄与炎症标志物及组织因子的关系[J]. 天津医药, 2019, 47(6): 646-650. https://www.cnki.com.cn/Article/CJFDTOTAL-TJYZ201906021.htm
|
[6] |
TANG X. Analysis of interleukin-17 and interleukin-18 levels in animal models of atherosclerosis[J]. Exp Ther Med, 2019, 18(1): 517-522. http://www.ingentaconnect.com/content/sp/etm/2019/00000018/00000001/art00064
|
[7] |
中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4): 246-257. doi: 10.3760/cma.j.issn.1006-7876.2015.04.002
|
[8] |
CUI B, YANG D, ZHENG W, et al. Plaque enhancement in multi-cerebrovascular beds associates with acute cerebral infarction[J]. Acta Radiol, 2021, 62(1): 102-112. doi: 10.1177/0284185120915604
|
[9] |
佟家旭, 姜学明, 刘莹莹. 颈动脉狭窄与急性脑梗死患者同型半胱氨酸、血小板参数及预后的相关性分析[J]. 实用医院临床杂志, 2020, 17(2): 119-122. doi: 10.3969/j.issn.1672-6170.2020.02.036
|
[10] |
MA G P, YANG B Z, ZHANG Y S, et al. Protective effects of miRNA-589 on cerebral ischemia-reperfusion injury[J]. J Biol Regul Homeost Agents, 2020, 34(4): 1269-1275.
|
[11] |
ZHANG H, WU J, WU J, et al. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice[J]. J Nanobiotechnology, 2019, 17(1): 29. doi: 10.1186/s12951-019-0461-7
|
[12] |
MCGEACHY M J, CUA D J, GAFFEN S L. The IL-17 family of cytokines in health and disease[J]. Immunity, 2019, 50(4): 892-906. doi: 10.1016/j.immuni.2019.03.021
|
[13] |
王娜, 卞玉杰, 田继新. 血清mir-210、HIF-1α水平与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的关系[J]. 中风与神经疾病杂志, 2020, 37(4): 302-305. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFSJ202004007.htm
|
[14] |
李力军, 叶家欣, 唐忠志, 等. miR-210对急性心肌梗死早期的诊断价值[J]. 中西医结合心脑血管病杂志, 2019, 17(18): 2819-2822. doi: 10.12102/j.issn.1672-1349.2019.18.026
|
[15] |
LI X, GUO D, CHEN Y, et al. Effects of altered levels of pro- and anti-inflammatory mediators on locations of in-stent reocclusions in elderly patients[J]. Mediators Inflamm, 2020, 23(2020): 1719279. http://www.researchgate.net/publication/345402459_Effects_of_Altered_Levels_of_Pro-_and_Anti-Inflammatory_Mediators_on_Locations_of_In-Stent_Reocclusions_in_Elderly_Patients
|
[16] |
TONTOWIPUTRO D K, SARGOWO D, TJOKROPRAWIRO A, et al. The significance of Agaricus blazei as an immunomodulator of the level of IL-17 in Balb/C mice with atherosclerosis[J]. Cent Eur J Immunol, 2020, 45(1): 1-8. doi: 10.5114/ceji.2020.94662
|
[17] |
张贵臣. 脑梗死患者血清hs-CRP、IL-17、IL-6水平及与NIHSS评分的相关性[J]. 检验医学与临床, 2020, 17(6): 834-837. doi: 10.3969/j.issn.1672-9455.2020.06.036
|
[18] |
LIU N, SU D, LIU K, et al. The effects of IL-17/IL-17R inhibitors on atherosclerosis in psoriasis and psoriatic arthritis: A protocol for systematic review and meta analysis[J]. Medicine (Baltimore), 2021, 100(6): e24549. doi: 10.1097/MD.0000000000024549
|
[19] |
林斯革, 陈皓, 蔡雪峰, 等. MiR-153通过调控keapl/nrf2/HO-1信号通路改善脑缺血再灌注后的炎症反应及保护神经元功能的研究[J]. 免疫学杂志, 2020, 36(9): 737-747. https://www.cnki.com.cn/Article/CJFDTOTAL-MYXZ202009001.htm
|
[20] |
YUE J N, LI W M, HONG W Z, et al. MiR-210 inhibits apoptosis of vascular endothelial cells via JAK-STAT in arteriosclerosis obliterans[J]. Eur Rev Med Pharmacol Sci, 2019, 23(3 Suppl): 319-326. http://www.ncbi.nlm.nih.gov/pubmed/31389592
|
1. |
木国法,李旭,龚应玲. 白细胞介素-4、瘦素、趋化素与肥胖型哮喘患儿病情程度的关系及预测哮喘控制的价值. 实用临床医药杂志. 2025(03): 108-113 .
![]() | |
2. |
杨洁. 儿保门诊小儿骨密度检测结果分析及干预. 婚育与健康. 2024(06): 97-99 .
![]() | |
3. |
高诗宇,吴力群,马佳,李盼盼,路晨,聂力. 基于网络药理学和分子对接技术探讨缓哮六安煎治疗儿童支气管哮喘的作用机制. 现代中西医结合杂志. 2022(11): 1513-1520 .
![]() | |
4. |
陈春娟,蔡剑英,刘凤林. 吸入性糖皮质激素长期低剂量应用对轻中度支气管哮喘儿童生长发育的影响分析. 贵州医药. 2022(10): 1574-1575 .
![]() | |
5. |
安家,李霞,李虹霖,杜淑玲. 小儿咳嗽变异性哮喘患儿骨代谢指标水平及其临床意义. 系统医学. 2022(21): 1-5 .
![]() |